Detalhe da pesquisa
1.
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Lancet
; 396(10254): 830-838, 2020 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877651
2.
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Am Heart J
; 210: 98-107, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30771737